Insulet Securities Litigation 

June 25, 2021. The Court in the Insulet securities matter (District Court of Massachusetts) approved a class action settlement in the amount of $19.5 million. Plaintiffs alleged that the company misled investors about the success of its new insulin infusion system, the system’s patient adoption and growth rates, and associated financial projections. Professor Steven Feinstein […]